Macquarie Group Ltd. Has $2.13 Million Holdings in LifePoint Health Inc (LPNT)

Macquarie Group Ltd. boosted its holdings in shares of LifePoint Health Inc (NASDAQ:LPNT) by 47.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,825 shares of the company’s stock after purchasing an additional 11,925 shares during the quarter. Macquarie Group Ltd. owned approximately 0.09% of LifePoint Health worth $2,132,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of LPNT. LSV Asset Management increased its holdings in LifePoint Health by 83.5% during the 2nd quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock worth $133,934,000 after purchasing an additional 907,469 shares during the last quarter. Victory Capital Management Inc. increased its holdings in LifePoint Health by 130.6% during the 2nd quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock worth $54,804,000 after purchasing an additional 462,211 shares during the last quarter. American Century Companies Inc. increased its holdings in LifePoint Health by 7.7% during the 3rd quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock worth $210,205,000 after purchasing an additional 260,944 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in LifePoint Health by 28.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock worth $46,044,000 after purchasing an additional 177,329 shares during the last quarter. Finally, Brandywine Global Investment Management LLC purchased a new stake in LifePoint Health during the 2nd quarter worth approximately $7,693,000. Institutional investors own 99.18% of the company’s stock.

In related news, Director Marguerite Kondracke sold 3,907 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 8.76% of the company’s stock.

LPNT has been the topic of several analyst reports. SunTrust Banks set a $60.00 price objective on LifePoint Health and gave the stock a “hold” rating in a report on Thursday, October 12th. BMO Capital Markets started coverage on LifePoint Health in a report on Monday, October 16th. They issued a “market perform” rating and a $59.00 price target for the company. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Raymond James Financial reiterated a “market perform” rating on shares of LifePoint Health in a report on Monday, October 30th. Finally, Robert W. Baird set a $55.00 price target on LifePoint Health and gave the company a “buy” rating in a report on Monday, October 30th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $60.23.

Shares of LifePoint Health Inc (NASDAQ LPNT) opened at $46.60 on Wednesday. LifePoint Health Inc has a twelve month low of $42.50 and a twelve month high of $70.95. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. The firm has a market capitalization of $1,828.89, a P/E ratio of 11.84, a PEG ratio of 1.21 and a beta of 0.67.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter last year, the firm posted $0.94 earnings per share. LifePoint Health’s revenue was down .7% compared to the same quarter last year. sell-side analysts predict that LifePoint Health Inc will post 3.64 earnings per share for the current fiscal year.

LifePoint Health declared that its board has initiated a share buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “Macquarie Group Ltd. Has $2.13 Million Holdings in LifePoint Health Inc (LPNT)” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://ledgergazette.com/2017/12/06/macquarie-group-ltd-has-2-13-million-holdings-in-lifepoint-health-inc-lpnt.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply